Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
University Health Network, Toronto
Eastern Cooperative Oncology Group
Jonsson Comprehensive Cancer Center
Umeå University
Royal North Shore Hospital
NRG Oncology
NRG Oncology
RTOG Foundation, Inc.
Mayo Clinic
M.D. Anderson Cancer Center
Stanford University
Milton S. Hershey Medical Center
Northwestern University
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center
Medical College of Wisconsin
IRCCS San Raffaele
IRCCS San Raffaele
University of Texas Southwestern Medical Center
University Hospital, Essen
University Health Network, Toronto
Milton S. Hershey Medical Center
Eastern Cooperative Oncology Group
CancerCare Manitoba
OHSU Knight Cancer Institute
Cancer Trials Ireland
University of Texas Southwestern Medical Center
NYU Langone Health
Jonsson Comprehensive Cancer Center
University Hospital, Geneva
Fox Chase Cancer Center
NRG Oncology
Mayo Clinic
Abramson Cancer Center at Penn Medicine
Stanford University
Stanford University
The Netherlands Cancer Institute
National Institutes of Health Clinical Center (CC)
ChineseAMS
Beth Israel Medical Center
National Cancer Institute (NCI)